Neural Mitochondrial Function
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DKK4 Antibody | Anmelden | DKK4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Monocarboxylate Transporter 2 (MCT2, MOT2) | Anmelden | Monocarboxylate Transporter 2 (MCT2, MOT2) | ||||||||||||||||
|
||||||||||||||||||
| Monocarboxylate Transporter 2 (MCT2, MOT2) | Anmelden | Monocarboxylate Transporter 2 (MCT2, MOT2) | ||||||||||||||||
|
||||||||||||||||||
| Monocarboxylate Transporter 2 (MCT2, MOT2) | Anmelden | Monocarboxylate Transporter 2 (MCT2, MOT2) | ||||||||||||||||
|
||||||||||||||||||
| BAX Antibody - N-terminal region | Anmelden | BAX Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| NDP Antibody - middle region | Anmelden | NDP Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| HSPA2 Antibody - middle region | Anmelden | HSPA2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| SYT11 Antibody - N-terminal region | Anmelden | SYT11 Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| SYT11 Antibody - N-terminal region | Anmelden | SYT11 Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| ZNF746 Antibody - middle region | Anmelden | ZNF746 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| LRP5, CT (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | Anmelden | LRP5, CT (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | Anmelden | LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | Anmelden | LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Kinase 2, RIP7, PARK8, Dardarin) | Anmelden | LRRK2 (Leucine-rich Repeat Kinase 2, RIP7, PARK8, Dardarin) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | Anmelden | LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) | ||||||||||||||||
|
||||||||||||||||||
| LRP5 (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | Anmelden | LRP5 (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | ||||||||||||||||
|
||||||||||||||||||
| Lipoprotein Receptor-related Protein 5, Low Density (LRP5, BMND1, HBM, HGNC:6697, LR3, LRP7, Osteoporosis Pseudoglioma Syndrome, OPPG, OPS, VBCH2) | Anmelden | Lipoprotein Receptor-related Protein 5, Low Density (LRP5, BMND1, HBM, HGNC:6697, LR3, LRP7, Osteoporosis Pseudoglioma Syndrome, OPPG, OPS, VBCH2) | ||||||||||||||||
|
||||||||||||||||||
| LRP5 (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | Anmelden | LRP5 (Low-density Lipoprotein Receptor-related Protein 5, LRP-5, LRP7) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Serine/Threonine-protein Kinase 2, Dardarin, PARK8) | Anmelden | LRRK2 (Leucine-rich Repeat Serine/Threonine-protein Kinase 2, Dardarin, PARK8) | ||||||||||||||||
|
||||||||||||||||||
| LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) (Biotin) | Anmelden | LRRK2 (Leucine-rich Repeat Kinase 2, Leucine-rich Repeat Serine/threonine Protein Kinase 2, AURA17, Dardarin, PARK8, RIPK7, ROCO2) (Biotin) | ||||||||||||||||
|
||||||||||||||||||
| ATXN7 Antibody - middle region | Anmelden | ATXN7 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| VAPA Antibody - C-terminal region | Anmelden | VAPA Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| CCND1 Antibody - middle region | Anmelden | CCND1 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| HSPA9 Antibody - C-terminal region | Anmelden | HSPA9 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| ILK Antibody - C-terminal region | Anmelden | ILK Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||


